Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsies
Open Access
- 5 August 2025
- journal article
- Published by Wiley in Histopathology
- Vol. 87 (5) , 717-725
Abstract
Aims: A dichotomous classifier for prostatic adenocarcinoma, favourable and unfavourable histology, was recently proposed to optimize metastasis prediction. We evaluate interobserver agreement for its classification.Methods and results: Fifty biopsies with prostatic adenocarcinoma were selected. One slide per biopsy was scanned using the Aperio AT2 scanner (20x) and viewed in Leica Web Viewer. Ten pathologists reviewed each slide after completing a training module. Biopsies were scored for Grade Group (1–5) and presence of unfavourable histology. Forty‐one of 50 biopsies (82%) had unanimous consensus [13 (32%) unfavourable and 28 (68%) favourable], 47 (94%) for at least 9 of 10 reviewers, and 48 (96%) for at least 8 of 10 reviewers. Percent agreement for favourable/unfavourable classification was 94%, kappa = 0.88 (95% CI: 0.8, 0.96), and Gwet's AC1 coefficient = 0.90 (95% CI: 0.82, 0.97) [both P‐value < 0.001]. Inter‐rater agreement for Grade Group designation was evaluated in biopsies with 100% consensus. In the favourable consensus group (n = 28), kappa for Grade Group was 0.80 (95% CI: 0.62, 0.98) and Kendall's W was 0.83 (95% CI: 0.81, 0.89), with both P‐value < 0.001. For the unfavourable consensus group (n = 13), kappa for Grade Group was 0.56 (95% CI: 0.36, 0.75) and Kendall's W was 0.78 (95% CI: 0.76, 0.85), with both P‐value < 0.001.Conclusions: The classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement, even when learnt through a simple tutorial. GG designation was more variable. This provides evidence that the favourable/unfavourable classification could be utilized in routine practice given its ease of use.Keywords
This publication has 43 references indexed in Scilit:
- Significance of the cribriform morphology area ratio for biochemical recurrence in Gleason score 4 + 4 prostate cancer patients following robot‐assisted radical prostatectomyCancer Medicine, 2024
- Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN ToolsClinical Genitourinary Cancer, 2023
- Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimensWorld Journal of Urology, 2022
- Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn‐ or metachronous metastatic diseaseThe Prostate, 2021
- Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinomaEuropean Journal of Cancer, 2016
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason ScoreEuropean Urology, 2016
- Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsyVirchows Archiv, 2015
- Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologistsAnnals of Diagnostic Pathology, 2014
- Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason gradingVirchows Archiv, 2011
- Should We Replace the Gleason Score with the Amount of High-Grade Prostate Cancer?European Urology, 2007